The baboon (Papio spp.) as a model of human ebola virus infection

Viruses

Volumn 4, Issue 10, 2012, Pages 2400-2416

  Perry, Donna L ^a   Bollinger, Laura ^a   White, Gary L ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Baboon; BSL 4; Ebola virus; Filoviridae; Filovirus; Marburg virus; Papio spp.

Indexed keywords

CREATININE; DNA; FIBRIN; FIBRINOGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G3; NITROGEN; PROTHROMBIN; THROMBIN; UREA; VIRUS VACCINE;

ADRENAL NECROSIS; ANIMAL BEHAVIOR; ANIMAL HOUSING; ANIMAL HUSBANDRY; BABOON; BLEEDING TENDENCY; BLOOD CLOTTING PARAMETERS; BONE MARROW BIOPSY; CREATININE BLOOD LEVEL; DISEASE MODEL; DISEASE PREDISPOSITION; DNA SEQUENCE; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FIBRIN DEPOSITION; FLU LIKE SYNDROME; GRANULOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; INOCULATION; KIDNEY FAILURE; LYMPHOCYTOPENIA; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; NONHUMAN; PATHOPHYSIOLOGY; PROPHYLAXIS; REVIEW; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; UREA NITROGEN BLOOD LEVEL; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BASE SEQUENCE; BLOOD COAGULATION FACTORS; DISEASE MODELS, ANIMAL; EBOLAVIRUS; FIBRIN; HEMORRHAGIC FEVER, EBOLA; HUMANS; LYMPHATIC DISEASES; MARBURG VIRUS DISEASE; MARBURGVIRUS; NECROSIS; PAPIO; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; THROMBOCYTOPENIA;

EBOLA VIRUS; FILOVIRIDAE; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS; PAPIO; PRIMATES;

EID: 84868107490     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4102400     Document Type: Review

References (77)

1. Chen, G.; Sun, H.; Yang, H.; Kubelik, D.; Garcia, B.; Luo, Y.; Xiang, Y.; Qian, A.; Copeman, L.; Liu, W.; et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006, 81, 273-283.
2. Davila, E.; Byrne, G.W.; LaBreche, P.T.; McGregor, H.C.; Schwab, A.K.; Davies, W.R.; Rao, V.P.; Oi, K.; Tazelaar, H.D.; Logan, J.S.; et al. T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 2006, 13, 31-40.
3. Ramirez, P.; Montoya, M.J.; Rios, A.; Garcia Palenciano, C.; Majado, M.; Chavez, R.; Munoz, A.; Fernandez, O.M.; Sanchez, A.; Segura, B.; et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc 2005, 37, 4103-4106.
4. Tseng, Y.L.; Kuwaki, K.; Dor, F.J.; Shimizu, A.; Houser, S.; Hisashi, Y.; Yamada, K.; Robson, S.C.; Awwad, M.; Schuurman, H.J.; Sachs, D.H.; et al. Alpha 1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005, 80, 1493-500.
5. Wallis, J. Synchrony of menstrual cycles in captive group living baboons (Papio cynocephalus and P. anubis). Am. J. Primatol. 1989, 18, 167.
6. Balasuriya, H.; Bell, P.; Waugh, R.; Thompson, J.; Gillin, A.; Hennessy, A.; Makris, A. Primate maternal placental angiography. Placenta 2010, 31, 32-36.
7. Joy, S.D.; O'Shaughnessy, R.; Schlabritz-Loutsevitch, N.; Leland, M.M.; Frost, P.; Fan-Havard, P. Fetal blood sampling in baboons (Papio spp.): Important procedural aspects and literature review. J. Med. Primatol. 2009, 38, 151-155.
8. White, G.L. University of Oklahoma, Ft. Reno Science Park, OK, USA. Personal communication, 2012.
9. Wolf, R.F.; Eberle, R.; White, G.L. Generation of a specific-pathogen-free baboon colony. J. Am. Assoc. Lab. Anim. Sci. 2010, 49, 814-820.
10. Langergraber, K.E.; Prufer, K.; Rowney, C.; Boesch, C.; Crockford, C.; Fawcett, K.; Inoue, E.; Inoue-Muruyama, M.; Mitani, J.C.; Muller, M.N.; et al. Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution. Proc. Natl. Acad. Sci. USA 2012, 109, 15716-15721.
11. Murthy, K.K.; Salas, M.T.; Carey, K.D.; Patterson, J.L. Baboon as a nonhuman primate model for vaccine studies. Vaccine 2006, 24, 4622-4624.
12. Shearer, M.H.; Dark, R.D.; Chodosh, J.; Kennedy, R.C. Comparison and characterization of immunoglobulin G subclasses among primate species. Clin. Diagn. Lab. Immunol. 1999, 6, 953-958.
13. Williamson, E.D.; Packer, P.J.; Waters, E.L.; Simpson, A.J.; Dyer, D.; Hartings, J.; Twenhafel, N.; Pitt, M.L. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague. Vaccine 2011, 29, 4771-4777.
14. Kam, Y.W.; Simarmata, D.; Chow, A.; Her, Z.; Teng, T.S.; Ong, E.K.; Renia, L.; Leo, Y.S.; Ng, L.F. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J. Infect. Dis. 2012, 205, 1147-1154.
15. Papin, J.F.; Verardi, P.H.; Jones, L.A.; Monge-Navarro, F.; Brault, A.C.; Holbrook, M.R.; Worthy, M.N.; Freiberg, A.N.; Yilma, T.D. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice. Proc. Natl. Acad. Sci. USA 2011, 108, 14926-14931.
16. Wolf, R.F.; Papin, J.F.; Hines-Boykin, R.; Chavez-Suarez, M.; White, G.L.; Sakalian, M.; Dittmer, D.P. Baboon model for West Nile virus infection and vaccine evaluation. Virology 2006, 355, 44-51.
17. Coalson, J.J.; Benjamin, B.; Archer, L.T.; Beller, B.; Gilliam, C.L.; Taylor, F.B.; Hinshaw, L.B. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ. Shock 1978, 5, 423-437.
18. Hinshaw, L.B.; Emerson, T.E., Jr.; Taylor, F.B., Jr.; Chang, A.C.; Duerr, M.; Peer, G.T.; Flournoy, D.J.; White, G.L.; Kosanke, S.D.; Murray, C.K.; et al. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J. Trauma 1992, 33, 568-573.
19. Taylor, F.B., Jr.; Kosanke, S.; Randolph, M.; Emerson, T.; Hinshaw, L.B.; White, G.L.; Chang, A.C.; Peer, G.; Blick, K. Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli. Circ. Shock 1994, 42, 92-103.
20. Silasi-Mansat, R.; Zhu, H.; Popescu, N.I.; Peer, G.; Sfyroera, G.; Magotti, P.; Ivanciu, L.; Lupu, C.; Mollnes, T.E.; Taylor, F.B.; et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 2010, 116, 1002-1010.
21. Stearns-Kurosawa, D.J.; Lupu, F.; Taylor, F.B., Jr.; Kinasewitz, G.; Kurosawa, S. Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am. J. Pathol. 2006, 169, 433-444.
22. Leroy, E.M.; Telfer, P.; Kumulungui, B.; Yaba, P.; Rouquet, P.; Roques, P.; Gonzalez, J.P.; Ksiazek, T.G.; Rollin, P.E.; Nerrienet, E. A serological survey of Ebola virus infection in central African nonhuman primates. J. Infect. Dis. 2004, 190, 1895-1899.
23. Luchko, S.V.; Dadaeva, A.A.; Ustinova, E.N.; Sizikova, L.P.; Riabchikova, E.I.; Sandakhchiev, L.S. Experimental study of Ebola hemorrhagic fever in baboon models. Biull. Eksp. Biol. Med. 1995, 120, 302-304.
24. Mikhailov, V.V.; Borisevich, I.V.; Chernikova, N.K.; Potryvaeva, N.V.; Krasnianskii, V.P. The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever. Vopr. Virusol. 1994, 39, 82-84.
25. Ignatiev, G.M.; Dadaeva, A.A.; Luchko, S.V.; Chepurnov, A.A. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol. Lett. 2000, 71, 131-140.
26. Ryabchikova, E.I.; Kolesnikova, L.V.; Luchko, S.V. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis. 1999, 179, S199-S202.
27. Kuhn, J.H.; Becker, S.; Ebihara, H.; Geisbert, T.W.; Johnson, K.M.; Kawaoka, Y.; Lipkin, W.I.; Negredo, A.I.; Netesov, S.V.; Nichol, S.T.; et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 2010, 155, 2083-2103.
28. Adams, M.J.; Carstens, E.B. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Arch. Virol. 2012, 157, 1411-1422.
29. Marty, A.M.; Jahrling, P.B.; Geisbert, T.W. Viral hemorrhagic fevers. Clin. Lab. Med. 2006, 26, 345-386.
30. Bray, M. Pathogenesis of viral hemorrhagic fever. Curr. Opin. Immunol. 2005, 17, 399-403.
31. Maganga, G.D.; Bourgarel, M.; Ella, G.E.; Drexler, J.F.; Gonzalez, J.P.; Drosten, C.; Leroy, E.M. Is Marburg virus enzootic in Gabon? J. Infect. Dis. 2011, 204, S800-S803.
32. Martini, G.A. Marburg virus disease. Postgrad. Med. J. 1973, 49, 542-546.
33. Leroy, E.M.; Gonzalez, J.P.; Baize, S. Ebola and Marburg haemorrhagic fever viruses: Major scientific advances, but a relatively minor public health threat for Africa. Clin. Microbiol. Infect. 2011, 17, 964-976.
34. Geisbert, T.W.; Hensley, L.E.; Larsen, T.; Young, H.A.; Reed, D.S.; Geisbert, J.B.; Scott, D.P.; Kagan, E.; Jahrling, P.B.; Davis, K.J. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 2003, 163, 2347-2370.
35. Hensley, L.E.; Geisbert, T.W. The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates. Thromb. Haemost. 2005, 94, 254-261.
36. Ascenzi, P.; Bocedi, A.; Heptonstall, J.; Capobianchi, M.R.; Di Caro, A.; Mastrangelo, E.; Bolognesi, M.; Ippolito, G. Ebolavirus and Marburgvirus: insight the Filoviridae family. Mol. Aspects. Med. 2008, 29, 151-185.
37. Kortepeter, M.G.; Bausch, D.G.; Bray, M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J. Infect. Dis. 2011, 204, S810-S816.
38. Zampieri, C.A.; Sullivan, N.J.; Nabel, G.J. Immunopathology of highly virulent pathogens: Insights from Ebola virus. Nat. Immunol. 2007, 8, 1159-1164.
39. Roddy, P.; Thomas, S.L.; Jeffs, B.; Nascimento Folo, P.; Pablo Palma, P.; Moco, H.B.; Villa, L.; Damiao Machado, F.P.; Bernal, O.; Jones, S.M.; et al. Factors associated with Marburg hemorrhagic fever: Analysis of patient data from Uige, Angola. J. Infect. Dis. 2010, 201, 1909-1918.
40. Nikiforov, V.V.; Turovskii Iu, I.; Kalinin, P.P.; Akinfeeva, L.A.; Katkova, L.R.; Barmin, V.S.; Riabchikova, E.I.; Popkova, N.I.; Shestopalov, A.M.; Nazarov, V.P.; et al. A case of a laboratory infection with Marburg fever. Zh. Mikrobiol. Epidemiol. Immunobiol. 1994, 3, 104-106.
41. Kissling, R.E.; Murphy, F.A.; Henderson, B.E. Marburg virus. Ann. N.Y. Acad. Sci. 1970, 174, 932-945.
42. Sureau, P.H. Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev. Infect. Dis. 1989, 11, S790-S793.
43. Ebola haemorrhagic fever in Zaire, 1976. Bull. World. Health Organ. 1978, 56, 271-293.
44. Adjemian, J.; Farnon, E.C.; Tschioko, F.; Wamala, J.F.; Byaruhanga, E.; Bwire, G.S.; Kansiime, E.; Kagirita, A.; Ahimbisibwe, S.; Katunguka, F.; et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J. Infect. Dis. 2011, 204, S796-S799.
45. Smith, D.H.; Johnson, B.K.; Isaacson, M.; Swanapoel, R.; Johnson, K.M.; Killey, M.; Bagshawe, A.; Siongok, T.; Keruga, W.K. Marburg-virus disease in Kenya. Lancet 1982, 1, 816-820.
46. Heymann, D.L.; Weisfeld, J.S.; Webb, P.A.; Johnson, K.M.; Cairns, T.; Berquist, H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J. Infect. Dis. 1980, 142, 372-376.
47. Ndambi, R.; Akamituna, P.; Bonnet, M.J.; Tukadila, A.M.; Muyembe-Tamfum, J.J.; Colebunders, R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999, 179, S8-S10.
48. Richards, G.A.; Murphy, S.; Jobson, R.; Mer, M.; Zinman, C.; Taylor, R.; Swanepoel, R.; Duse, A.; Sharp, G.; De La Rey, I.C.; Kassianides, C. Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects. Crit. Care Med. 2000, 28, 240-244.
49. Mahanty, S.; Bray, M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect. Dis. 2004, 4, 487-498.
50. Solbrig, M.V.; Naviaux, R.K. Review of the neurology and biology of Ebola and Marburg virus infections. Neurolog. Infect. Epidemiol. 1997, 2, 5-12.
51. Rollin, P.E.; Bausch, D.G.; Sanchez, A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J. Infect. Dis. 2007, 196, S364-S371.
52. Murphy, F.A. Pathology of Ebola Virus Infection. In Ebola Virus Haemorrhagic Fever: Colloquium Proceedings; Pattyn, S.R., Ed.; Elsevier/North-Holland Biomedical Press: New York, NY, USA, 1978.
53. Geisbert, T.W.; Hensley, L.E. Ebola virus: New insights into disease aetiopathology and possible therapeutic interventions. Expert. Rev. Mol. Med. 2004, 6, 1-24.
54. van Paassen, J.; Bauer, M.P.; Arbous, M.S.; Visser, L.G.; Schmidt-Chanasit, J.; Schilling, S.; Olschlager, S.; Rieger, T.; Emmerich, P.; Schmetz, C.; et al. Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever. Lancet Infect. Dis. 2012, 12, 635-642.
55. Sanchez, A.; Lukwiya, M.; Bausch, D.; Mahanty, S.; Sanchez, A.J.; Wagoner, K.D.; Rollin, P.E. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol. 2004, 78, 10370-10377.
56. Martini, G.A. Marburg Virus Disease: Clinical Syndrome. In Marburg Virus Disease; Martini, G.A., Siegert, R., Eds.; Springer Verlag: Berlin, Germany, 1971; pp. 1-9.
57. Geisbert, T.W.; Young, H.A.; Jahrling, P.B.; Davis, K.J.; Kagan, E.; Hensley, L.E. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J. Infect. Dis. 2003, 188, 1618-1629.
58. Geisbert, T.W.; Young, H.A.; Jahrling, P.B.; Davis, K.J.; Larsen, T.; Kagan, E.; Hensley, L.E. Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am. J. Pathol. 2003, 163, 2371-2382.
59. Gear, J.S.; Cassel, G.A.; Gear, A.J.; Trappler, B.; Clausen, L.; Meyers, A.M.; Kew, M.C.; Bothwell, T.H.; Sher, R.; Miller, G.B.; et al. Outbreak of Marburg virus disease in Johannesburg. Br. Med. J. 1975, 4, 489-493.
60. Formenty, P.; Hatz, C.; Le Guenno, B.; Stoll, A.; Rogenmoser, P.; Widmer, A. Human infection due to Ebola virus, subtype Cote d'Ivoire: Clinical and biologic presentation. J. Infect. Dis. 1999, 179, S48-S53.
61. Todorovitch, K.; Mocitch, M.; Klasnja, R. Clinical Picture of Two Patients Infected by the Marburg Vervet Virus. In Marburg Virus Disease; Martini, G.A., Siegert, R., Eds.; Springer-Verlag: Berlin, Germany, 1971; pp. 19-23.
62. Bonnet, M.J.; Akamituna, P.; Mazaya, A. Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg. Infect. Dis. 1998, 4, 508-510.
63. Valeri, C.R.; MacGregor, H.; Cassidy, G.; Tinney, R.; Pompei, F. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit. Care Med. 1995, 23, 698-704.
64. Stone, R.; Seymour, J.; Marshall, O. Plastic containers and the whole-blood clotting test: Glass remains the best option. Trans. Roy. Soc. Trop. Med. Hyg. 2006, 100, 1168-1172.
65. Matevosyan, K.; Madden, C.; Barnett, S.L.; Beshay, J.E.; Rutherford, C.; Sarode, R.C. Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy. J. Neurosurg. 2011, 114, 3-7.
66. Stille, W.; Bohle, E. Clinical Course and Prognosis of Marburg Virus ("green-monkey") Disease. In Marburg Virus Disease; Martini, G.A., Siegert, R., Eds.; Springer Verlag: Berlin, Germany, 1971; pp. 10-18.
67. Zaki, S.R.; Goldsmith, C.S. Pathologic features of filovirus infections in humans. Curr. Top. Microbiol. Immunol. 1999, 235, 97-116.
68. Geisbert, T.W.; Jaax, N.K. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct. Pathol. 1998, 22, 3-17.
69. Geisbert, T.W.; Jahrling, P.B. Differentiation of filoviruses by electron microscopy. Virus Res. 1995, 39, 129-150.
70. Havemann, K.; Schmidt, H.A. Haematological Findings in Marburg Virus Disease: Evidence for Involvement of the Immunological System. In Marburg Virus Disease; Martini, G.A., Siegert, R., Eds.; Springer-Verlag: Berlin, Germany, 1971; pp. 34-40.
71. Jahrling, P.B.; Marty, A.M.; Geisbert, T.W. Viral Hemorrhagic Fevers. In Medical Aspects of Biological Warfare; Dembek, Z.F., Ed.; Borden Institute: Washington, DC, USA, 2008; pp. 271-310.
72. Kortepeter, M.G.; Lawler, J.V.; Honko, A.; Bray, M.; Johnson, J.C.; Purcell, B.K.; Olinger, G.G.; Rivard, R.; Hepburn, M.J.; Hensley, L.E. Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus. J. Infect. Dis. 2011, 204, S1000-S1010.
73. Hensley, L.E.; Alves, D.A.; Geisbert, J.B.; Fritz, E.A.; Reed, C.; Larsen, T.; Geisbert, T.W. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J. Infect. Dis. 2011, 204, S1021-S1031.
74. Lub, M.; Sergeev, A.N.; P'Iankov, O.V.; P'Iankova, O.G.; Petrishchenko, V.A.; Kotliarov, L.A. Certain pathogenetic characteristics of a disease in monkeys in infected with the Marburg virus by an airborne route. Vopr. Virusol. 1995, 40, 158-161.
75. Fisher-Hoch, S.P.; Brammer, T.L.; Trappier, S.G.; Hutwagner, L.C.; Farrar, B.B.; Ruo, S.L.; Brown, B.G.; Hermann, L.M.; Perez-Oronoz, G.I.; Goldsmith, C.S.; et al. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J. Infect. Dis. 1992, 166, 753-763.
76. Bray, M.; Hatfill, S.; Hensley, L.; Huggins, J.W. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J. Comp. Pathol. 2001, 125, 243-253.
77. Ryabchikova, E.I.; Price, B.B. Ebola and Marburg Viruses: A View of Infection Using Electron Microscopy; Batelle Press: Columbus, OH, USA, 2004.